|
PPAP2B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.949800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.129600E-01 |
| Normal-vs-Stage2 |
9.127400E-01 |
| Normal-vs-Stage3 |
9.099300E-03 |
| Normal-vs-Stage4 |
3.319400E-03 |
| Stage1-vs-Stage2 |
9.534000E-01 |
| Stage1-vs-Stage3 |
1.884620E-03 |
| Stage1-vs-Stage4 |
1.562190E-03 |
| Stage2-vs-Stage3 |
2.872500E-02 |
| Stage2-vs-Stage4 |
1.663800E-02 |
| Stage3-vs-Stage4 |
5.130600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.336000E-02 |
| Normal-vs-AfricanAmerican |
7.180200E-01 |
| Normal-vs-Asian |
4.767200E-01 |
| Caucasian-vs-AfricanAmerican |
4.612600E-01 |
| Caucasian-vs-Asian |
1.978240E-02 |
| AfricanAmerican-vs-Asian |
4.290200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.249600E-02 |
| Normal-vs-Female |
3.422200E-01 |
| Male-vs-Female |
2.070000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.650000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.715820E-01 |
| Normal-vs-Age(61-80Yrs) |
2.361900E-02 |
| Normal-vs-Age(81-100Yrs) |
1.226370E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.799500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.901600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.085700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.176800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.298810E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.927800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.60409999727662E-08 |
| Classical-VS-Follicular |
4.779600E-02 |
| Classical-VS-Other |
2.657800E-01 |
| Classical-VS-Normal |
3.212800E-01 |
| Tall-VS-Follicular |
1.47399999983477E-08 |
| Tall-VS-Other |
2.880800E-01 |
| Tall-VS-Normal |
1.94329999980702E-07 |
| Follicular-VS-Other |
1.278450E-01 |
| Follicular-VS-Normal |
4.482200E-01 |
| Other-VS-Normal |
8.424000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.005200E-01 |
| Normal-vs-N1 |
5.981000E-03 |
| N0-vs-N1 |
3.816400E-03 |
|
|
